The company has crossed $100 million in annual recurring revenue as enterprises clean up their data to train AI models.
Glean, a maker of search chatbots and agents for businesses, has more than doubled its customer base in the last year alone, ...
The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower growth this year.
Learn more about whether Glaukos Corporation or Inari Medical, Inc. is a better investment based on AAII's A+ Investor grades ...
Boston Scientific apparently knows a good bet when it sees one. | That includes treating more than 200,000 patients with the ...
NOVATO, Calif. - Ultragenyx Pharmaceutical Inc. (NASDAQ: NASDAQ:RARE), a $4.08 billion market cap biotechnology company with 27% revenue growth in the past year, today unveiled new data indicating ...
Zydus Lifesciences reported 29.62% jump in consolidated net profit of Rs 1,023.5 crore inQ3 FY25 compared with Rs 789.6 crore in Q3 FY24.
MINNEAPOLIS, Feb. 04, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. ("CVRx"), a commercial-stage medical device company focused on ...
Oscar Health reported a $25 million profit for the full year 2024 as the provider of individual Obamacare health insurance ...
The cuts at two Massachusetts plants follow further site closures and layoffs across the company over the past few years.
Bristol-Myers Squibb (NYSE:BMY), a global biopharmaceutical giant with a market capitalization of $120.8 billion, finds ...
Learn more about whether Blueprint Medicines Corporation or Zai Lab Limited is a better investment based on AAII's A+ ...